Fidelio 2018-12-14T13:39:09+00:00

FIDELIO HEALTHCARE PARTNERS

Fidelio Healthcare Partners is a company offering global consulting services for the healthcare and life science industry located in Seefeld, Germany. Fidelio Healthcare Partners was established in 2015 by Heiner Hoppmann and Dr. Christian Zischek. Our core competencies comprise consulting and advisory in Strategy Management, M&A support, performance enhancement in Supply Chain and Operations including Lean Management Implementation, R&D Project Management, Quality Management, and Interim and Project Management.

FIDELIO HEALTHCARE PARTNERS

Fidelio Healthcare Partners is a company offering global consulting services for the healthcare and life science industry located in Seefeld, Germany.Fidelio Healthcare Partners was established in 2015 by Heiner Hoppmann and Dr. Christian Zischek. Our core competencies comprise consulting and advisory in Strategy Management, M&A support, performance enhancement in Supply Chain and Operations including Lean Management Implementation, R&D Project Management, Quality Management, and Interim and Project Management.

OUR SERVICES

fidelio healthcare services

M & A Support

Acquisition, divestiture,
or mergers of Companies, Products
or Company assets…

READ MORE >

Strategic Management
Consulting

From an elaboration of a vision,
through development of a strategy
to preparation of a road map…

READ MORE >

fidelio healthcare services
fidelio healthcare services

Strategic Management
Consulting

From an elaboration of a vision,
through development of a strategy
to preparation of a road map…

READ MORE >

fidelio healthcare services

Supply Chain and
Operations Consulting

We can create value in optimizing
your entire supply chain at different
levels…

READ MORE >

R&D Management and
Regulatory Services

Our team has a proven track record
of strengthening the business and
scientific aspects of drug product
development…

READ MORE >

fidelio healthcare services
fidelio healthcare services

R&D Management and
Regulatory Services

Our team has a proven track record
of strengthening the business and
scientific aspects of drug product
development…

READ MORE >

Quality Management

We can help your Quality function
on its way to provide state of the art
support for your technical operations…

READ MORE >

Interim Management

We can deliver all areas of our
expertise throughout the entire value
chain on an interim management basis…

READ MORE >

fidelio healthcare services
fidelio healthcare services

Interim Management

We can deliver all areas of our
expertise throughout the entire value
chain on an interim management basis…

READ MORE >

OUR PARTNER CONCEPT

All our partners have a longstanding track record in the healthcare industry comprising pharmaceuticals, radiopharmaceuticals, veterinary, medical technology, and consumer care including food supplements and cosmetics. Based on this broad range of experience, our partners have expertise in General Management, M&A Transaction Services, all aspects of Pharmaceutical Operations including end-to-end Supply Chain Management, Quality Management, Research & Development, Business Development and Pipeline Management.

Our partners can look back to 15 to 35 years of experience offering international and multicultural background. They work individually or as a team depending on project size and complexity. Due to their management experience as proven leaders they provide capabilities in design, set-up and successful execution of projects. If appropriate, we work together with specialized consultants from our network.

OUR PARTNER CONCEPT

All our partners have a longstanding track record in the healthcare industry comprising pharmaceuticals, radiopharmaceuticals, veterinary, medical technology, and consumer care including food supplements and cosmetics. Based on this broad range of experience, our partners have expertise in General Management, M&A Transaction Services, all aspects of Pharmaceutical Operations including end-to-end Supply Chain Management, Quality Management, Research & Development, Business Development and Pipeline Management.

Our partners can look back to 15 to 35 years of experience offering international and multicultural background. They work individually or as a team depending on project size and complexity. Due to their management experience as proven leaders they provide capabilities in design, set-up and successful execution of projects. If appropriate, we work together with specialized consultants from our network.

ABOUT US

fidelio healthcare hoppmann

Heiner Hoppmann
Founding Partner

Heiner Hoppmann was founder and CEO of Aenova Group until 2015. He has more than 30 years of industry experience in senior and top management positions at Hoechst, Schering, Ratiopharm, Siegfried, and Aenova Group. Under his leadership, Aenova grew within seven years from a 200 Mio€ mid-sized CMO to the Europe’s leading CDMOs with more than 750 Mio€ in sales, making it the global number 3 in the CDMO industry. His broad expertise covers all areas of the pharmaceutical value chain, from strategy and corporate development (including M&A and finance) to business development and operations (including R&D, supply chain management, sourcing and manufacturing). Heiner is a pharmacist by training.

Since founding Fidelio Healthcare Partners, he has supported a significant number of transactions as senior advisor and consultant for various investment funds, and has been working closely with a series of mid-sized pharma companies on strategic transformation projects.

Dr. Christian Zischek
Founding Partner

As head of Corporate Development and M&A, Dr. Christian Zischek was responsible for a total of 12 acquisitions and transactions of the Aenova group, growing the company from 250 Mio € sales to 750 Mio € within three years. As CEO USA he also was responsible for the group’s US business. Christian has a strong background in top management consulting with BCG, where he was responsible for a broad range of strategic and transformational projects for top-tier clients in the pharma and health care industry in Europe and the USA. By training, he is a Medical Doctor and holds an MBA from INSEAD.

Since co-founding Fidelio Healthcare Partners, Christian has been supporting various clients on strategic questions, mainly related to M&A activities, partnerships, and market entry / product launches.

fidelio healthcare zischek
fidelio healthcare zischek

Dr. Christian Zischek
Founding Partner

As head of Corporate Development and M&A, Dr. Christian Zischek was responsible for a total of 12 acquisitions and transactions of the Aenova group, growing the company from 250 Mio € sales to 750 Mio € within three years. As CEO USA he also was responsible for the group’s US business. Christian has a strong background in top management consulting with BCG, where he was responsible for a broad range of strategic and transformational projects for top-tier clients in the pharma and health care industry in Europe and the USA. By training, he is a Medical Doctor and holds an MBA from INSEAD.

Since co-founding Fidelio Healthcare Partners, Christian has been supporting various clients on strategic questions, mainly related to M&A activities, partnerships, and market entry / product launches.

Dr. Thomas Uhlmann
Partner

Dr. Thomas Uhlmann has been active in the life sciences industry since 1999. He held international senior management positions at Roche, Schering, Acino and Aenova as Project Manager, Site-Manager, Managing Director and Regional Manager of Production Sites with line responsibility for up to 700 employees and turn-over responsibility for more than 120 Mio €. Thomas‘ expertise covers end-to-end supply chain management, development and manufacturing of all pharmaceutical forms with a focus on solid and special dosage forms.

Thomas has a strong track record in organizational development and cultural change. In the field of Lean Management, he has co-developed and applied the SLIM©-Method for the Successful Implementation of Lean Management in Organizations.

By training he is a Pharmacist, holds a PhD in Pharmaceutical Technology from the University in Freiburg and a Degree in Economics from the University in Bayreuth.

Dr. Claus Rubensdörfer
Partner

Dr. Claus Rubensdörfer has more than 20 years of experience in life science industry as Managing Director and Regional Manager within the Bayer and Schering supply network covering pharmaceuticals, radiopharmaceuticals and consumer care. His multicultural background and recognized integration capabilities are built on a bilingual education and several international assignments including strategic project management in APAC and Latin America.

He was heading sites in Germany, Spain, France and Brazil including Third Party Manufacturing with sales up to 100 Mio € and led several integration projects.

By training he is pharmacist with a PhD in Pharmaceutical Technology and has a strong background in optimization of end-to-end supply chain processes and operational excellence. He joined Fidelio Healthcare Partners in 2017.

fidelio healthcare rubensdörfer
fidelio healthcare rubensdörfer

Dr. Claus Rubensdörfer
Partner

Dr. Claus Rubensdörfer has more than 20 years of experience in life science industry as Managing Director and Regional Manager within the Bayer and Schering supply network covering pharmaceuticals, radiopharmaceuticals and consumer care. His multicultural background and recognized integration capabilities are built on a bilingual education and several international assignments including strategic project management in APAC and Latin America.

He was heading sites in Germany, Spain, France and Brazil including Third Party Manufacturing with sales up to 100 Mio € and led several integration projects.

By training he is pharmacist with a PhD in Pharmaceutical Technology and has a strong background in optimization of end-to-end supply chain processes and operational excellence. He joined Fidelio Healthcare Partners in 2017.

Fidelio Healthcare Bock

Dr. Michael Bock
Associated Partner

Michael Bock has more than 30 years experience in the Healthcare Industry in various positions and levels along the life cycle of products. He was leading supply networks of up to 20 manufacturing sites and 20 contract manufacturers in OTC Latin & North America for Bayer and in Pharmaceuticals for Schering to support the respective sales of 1-2 bio€. Additionally, Michael managed several M&A projects within his area of responsibility (acquisitions, divestures). As Head of Strategic Procurement at Bayer Healthcare, Michael accounted for costs savings within a 1.2 bio€ spend in contract manufacturing and packaging materials and implemented a make-or-buy guideline. Other positions were R&D project manager for diagnostic imaging agents, medical devices or CMC development, leading intercultural and crossfunctional teams, and Quality Manager for 10 years in different functions.

Michael by education is an organic chemist. His major expertise is in managing cross- cultural/functional teams in PS and R&D, especially in Asia and Latin America, project management, M&A and divesture projects, strategic procurement and supplier relationship management.

Dr. Andreas König
Associated Partner

Andreas König has more than 20 years experience in pharmaceutical industry. In his last position, he acted as Senior Vice President for corporate Quality and HSE at Aenovas 18 manufacturing sites. In this position he integrated the Haupt Pharma quality units and prepared several successful FDA inspections. Prior to this he was heading Aenova’s entire manufacturing network with 11 manufacturing sites. He consolidated the network by closing five manufacturing sites and bringing the volumes to the remaining sites.

Andreas was holding corporate leadership functions in quality and manufacturing at Aenova (D), Schering Plough (USA), Intervet (NL) and Fresenius-Kabi (D). In these companies he was leading complex organisations with up to 26 sites and headcounts up to more than 2000 people. He is a renowned speaker on several conferences where his passion are lectures on modern, effective and efficient quality systems. By training Andreas is pharmacist and holds a PhD from the University in Würzburg.

fidelio healthcare könig
fidelio healthcare könig

Dr. Andreas König
Associated Partner

Andreas König has more than 20 years experience in pharmaceutical industry. In his last position, he acted as Senior Vice President for corporate Quality and HSE at Aenovas 18 manufacturing sites. In this position he integrated the Haupt Pharma quality units and prepared several successful FDA inspections. Prior to this he was heading Aenova’s entire manufacturing network with 11 manufacturing sites. He consolidated the network by closing five manufacturing sites and bringing the volumes to the remaining sites.

Andreas was holding corporate leadership functions in quality and manufacturing at Aenova (D), Schering Plough (USA), Intervet (NL) and Fresenius-Kabi (D). In these companies he was leading complex organisations with up to 26 sites and headcounts up to more than 2000 people. He is a renowned speaker on several conferences where his passion are lectures on modern, effective and efficient quality systems. By training Andreas is pharmacist and holds a PhD from the University in Würzburg.

fidelio healthcare miteva

Yanitsa Miteva
Associated Partner

Yanitsa Miteva´s broad area of expertise covers a range of competencies in the technical and business aspects of projects, such as R&D, sales, business development, and technical operations. In her previous role, she was in charge of R&D sales at Aenova and oversaw the project portfolio extending over 80 development projects. Yanitsa has held progressive roles in Aenova´s R&D, most notably established and led the competence center for soft gelatin capsule technology. As project leader, Yanitsa has successfully managed transfer and development projects for originator and generic products intended for the EU and US markets.

Ms. Miteva graduated as pharmacist from the University of Heidelberg and is inventor of patents on oral dosage forms.

Dr. Armin Prasch
Associated Partner

In the course of his career stretching over more than 20 years, Armin Prasch has held various senior and executive positions in pharmaceutical R&D. In his last role as Senior Vice President R&D at Aenova, he built up a global R&D group of 180 scientists in pharmaceutical, analytical development, drug regulatory affairs and clinical services. Under his leadership, the R&D group grew to an annual R&D turnover of more than 20 million Euro and extended over 8 development sites with more than 120 projects. Until 2010, he held the position as CEO of Advanced Drug Delivery (ADD) Technologies, a pharmaceutical development company for solid dosage forms, and held executive management positions at Glatt Pharmaceutical Services.

Mr. Prasch graduated as Chemical Engineer and as PhD from the Technical University of Munich. He started his career as senior scientist at a Fraunhofer Research Institute. Armin Prasch is inventor of several patents in Pharmaceutical and Engineering Sciences.

fidelio healthcare prasch
fidelio healthcare prasch

Dr. Armin Prasch
Associated Partner

In the course of his career stretching over more than 20 years, Armin Prasch has held various senior and executive positions in pharmaceutical R&D. In his last role as Senior Vice President R&D at Aenova, he built up a global R&D group of 180 scientists in pharmaceutical, analytical development, drug regulatory affairs and clinical services. Under his leadership, the R&D group grew to an annual R&D turnover of more than 20 million Euro and extended over 8 development sites with more than 120 projects. Until 2010, he held the position as CEO of Advanced Drug Delivery (ADD) Technologies, a pharmaceutical development company for solid dosage forms, and held executive management positions at Glatt Pharmaceutical Services.

Mr. Prasch graduated as Chemical Engineer and as PhD from the Technical University of Munich. He started his career as senior scientist at a Fraunhofer Research Institute. Armin Prasch is inventor of several patents in Pharmaceutical and Engineering Sciences.

Uwe Scharwächter
Associated Partner

Uwe Scharwächter has been active in the life science industry for more than 25 years. During this time he held different executive and senior management positions at Hoechst, Hexal, Sandoz and Aenova. In his last role as VP TechOps & SCM Strategy for Aenova, he was responsible for building and improving a global production network and strategic engineering projects of 16 sites. Following a M&A strategy Uwe has integrated all sites from Dragenopharm GmbH, Swiss Caps AG, Temmler Pharma GmbH and Haupt Pharma GmbH into one operations network. Within that period he has also taken care of optimizing SCM processes and the implementation of an Operational Excellence system. Six site closures have led to net savings of > 20 Mio€.

Prior to this he was managing production sites and departments at Sandoz and Hexal, leading up to 300 employees, focus on production costs, capacity utilization, customer service and operational excellence.

Uwe graduated as pharmacist from the University Bonn. His expertise includes a broad range of pharmaceutical areas, SCM tasks and P&L and cost centre analysis. Uwe has a lot of experience in leading intercultural and cross-functional project teams, especially in terms of product transfers, restructuring processes, productivity measurements and site closures.

Dr. Burkhard Schlütermann
Associated Partner

For the past 25 years, Burkhard Schlütermann been responsible for technical R&D operations, including pharmaceutical and analytical development organizations and has been successful in obtaining marketing approval as NDAs and generic applications for immediate and modified release drug products. In his previous position, he has overseen Aenova‘s operational pharmaceutical and analytical development activities as Vice President R&D since 2011. Mr. Schlütermann held the position as CSO in the research and development organization of Advanced Drug Delivery (ADD) Technologies, Switzerland, and project leader and project team representative positions at Novartis/Ciba-Geigy in Switzerland and the US. His experience also includes the establishment of a network of CROs, as well as organizing and take-over of sponsor responsibility for various pharmacokinetic studies.

Burkhard graduated as pharmacist from the University of Münster and as PhD in Pharmaceutical Sciences from the University of Munich. He is the inventor of several patents on particle engineered APIs, oral dosage forms and associated manufacturing techniques.

fidelio healthcare schlütermann
fidelio healthcare schlütermann

Dr. Burkhard Schlütermann
Associated Partner

For the past 25 years, Burkhard Schlütermann been responsible for technical R&D operations, including pharmaceutical and analytical development organizations and has been successful in obtaining marketing approval as NDAs and generic applications for immediate and modified release drug products. In his previous position, he has overseen Aenova‘s operational pharmaceutical and analytical development activities as Vice President R&D since 2011. Mr. Schlütermann held the position as CSO in the research and development organization of Advanced Drug Delivery (ADD) Technologies, Switzerland, and project leader and project team representative positions at Novartis/Ciba-Geigy in Switzerland and the US. His experience also includes the establishment of a network of CROs, as well as organizing and take-over of sponsor responsibility for various pharmacokinetic studies.

Burkhard graduated as pharmacist from the University of Münster and as PhD in Pharmaceutical Sciences from the University of Munich. He is the inventor of several patents on particle engineered APIs, oral dosage forms and associated manufacturing techniques.

Dr. Axel Müller
Associated Partner

Dr. Axel Müller – by education a pharmacist with a PhD in Pharmaceutical Technology – has over 30 years of experience in management and consulting.

Axel worked for many years for STADA Arzneimittel AG in very different areas such as general management, operations, M&A, marketing and sales as well as communications and was finally 2010 to 2013 Executive Board Member of STADA for production and development executing at this time very successfully a Group-wide efficiency program for all operation functions.

Since 2014 Axel is working as Consultant – mainly but not only in the Pharmaceutical Industry. Before Axel joined Fidelio Healthcare as Associated Partner in 2018 he was for several years Director / Senior Advisor of the global consultancy network of Arthur D. Little.

His broad management expertise allows Axel a 360° view of all interrelated aspects of management topics and transformation processes across the entire business, such as development of corporate strategy and its implementation, analysis and optimisation of operational performance, acquisitions and divestment processes including due diligences, in- and out-licensing, marketing and sales strategies and even corporate communications including investor relations.

Dr. Axel Müller
Associated Partner

Dr. Axel Müller – by education a pharmacist with a PhD in Pharmaceutical Technology – has over 30 years of experience in management and consulting.

Axel worked for many years for STADA Arzneimittel AG in very different areas such as general management, operations, M&A, marketing and sales as well as communications and was finally 2010 to 2013 Executive Board Member of STADA for production and development executing at this time very successfully a Group-wide efficiency program for all operation functions.

Since 2014 Axel is working as Consultant – mainly but not only in the Pharmaceutical Industry. Before Axel joined Fidelio Healthcare as Associated Partner in 2018 he was for several years Director / Senior Advisor of the global consultancy network of Arthur D. Little.

His broad management expertise allows Axel a 360° view of all interrelated aspects of management topics and transformation processes across the entire business, such as development of corporate strategy and its implementation, analysis and optimisation of operational performance, acquisitions and divestment processes including due diligences, in- and out-licensing, marketing and sales strategies and even corporate communications including investor relations.

Dr. Walter Bühl
Associated Partner

Dr. Walter Bühl is a Senior Professional in pharmaceutical industry with a record of 30 years in Technical Operations and Supply Chain. During this time he held different executive and senior management positions at Heumann/Searle, Kneipp, Merckle/Ratiopharm and Teva. He is experienced in all standard manufacturing technologies and related equipment and was deeply involved in the construction of several pharma sites.

As Managing Director at Merckle/Ratiopharm he led an international site network and supply chain, including Indian operation. After the Ratiopharm acquisition by Teva he acted as integration manager for technical Operations, set up a common supply chain organization and an IT platform for Teva Europe to connect Teva sites and EU markets. As member of the Teva European Executive Team he has broad experience in EU pharma markets. Walter has a long experience in intercultural leadership and working relations with EU, North-America, India, China and Israel.

By education Walter is a pharmacist and holds a PhD in Pharmaceutical Biology from the Philipps University in Marburg.

Dr. Walter Bühl
Associated Partner

Dr. Walter Bühl is a Senior Professional in pharmaceutical industry with a record of 30 years in Technical Operations and Supply Chain. During this time he held different executive and senior management positions at Heumann/Searle, Kneipp, Merckle/Ratiopharm and Teva. He is experienced in all standard manufacturing technologies and related equipment and was deeply involved in the construction of several pharma sites.

As Managing Director at Merckle/Ratiopharm he led an international site network and supply chain, including Indian operation. After the Ratiopharm acquisition by Teva he acted as integration manager for technical Operations, set up a common supply chain organization and an IT platform for Teva Europe to connect Teva sites and EU markets. As member of the Teva European Executive Team he has broad experience in EU pharma markets. Walter has a long experience in intercultural leadership and working relations with EU, North-America, India, China and Israel.

By education Walter is a pharmacist and holds a PhD in Pharmaceutical Biology from the Philipps University in Marburg.

Thomas Ehmann
Associated Partner

Thomas Ehmann has worked for more than 20 years in the Healthcare Industry with international senior management positions at Ratiopharm/Teva and PHOENIX group. His expertise covers pharmaceutical distribution, retail, supply chain and services for pharmaceutical manufacturers (e.g. 3PL Services, Route to Market, Business Intelligence, Patient Adherence, Sales Support), HR and Legal.

Thomas has a proven track record in General Management, Mergers & Acquisitions, Post Merger Integration, Restructuring and Change Management. Strong in developing, managing and executing new business opportunities and new strategies that support business deliverables, boost revenues, reduce costs, increase productivity and improve performance.

Thomas studied law at the University of Regensburg and started his career at the renowned law firm Gleiss Lutz.

Thomas Ehmann
Associated Partner

Thomas Ehmann has worked for more than 20 years in the Healthcare Industry with international senior management positions at Ratiopharm/Teva and PHOENIX group. His expertise covers pharmaceutical distribution, retail, supply chain and services for pharmaceutical manufacturers (e.g. 3PL Services, Route to Market, Business Intelligence, Patient Adherence, Sales Support), HR and Legal.

Thomas has a proven track record in General Management, Mergers & Acquisitions, Post Merger Integration, Restructuring and Change Management. Strong in developing, managing and executing new business opportunities and new strategies that support business deliverables, boost revenues, reduce costs, increase productivity and improve performance.

Thomas studied law at the University of Regensburg and started his career at the renowned law firm Gleiss Lutz.

OUR CLIENTS

Healthcare Companies

Financial Institutions

OUR CONTACT

Fidelio Healthcare Partners GmbH & Co. KG

Schlosshof 7
D- 82229 Seefeld . Germany
Phone: +49 8152 98 323 – 61
Fax: +49 8152 98 323 – 70

info@fidelio-healthcare.com
www.fidelio-healthcare.com

FOR MORE DETAILS, CLICK HERE >